Resolaris: Interim ATYR1940-C-005 extension study data

Interim data from 4 evaluable adult patients with FSHD in the open-label, international ATYR1940-C-005 extension of the 12-week Phase Ib/II ATYR1940-C-002 trial showed that once-weekly 3 mg/kg IV Reso...